CSO
Dash Bio, Inc
Newton, Massachusetts
Chief Scientific Officer at Dash Bio, Inc., and experienced CTO/CSO leader with a track record of building and scaling science-driven organizations. A biochemist and biological engineer passionate about translating next-generation therapies into the clinic, I’ve defined R&D and product strategies, led translational science and clinical teams, and established high-impact partnerships across academia and pharma. As a co-founder and technology leader in synthetic immunology, I shaped the IP roadmap, facilitated the build-out of a bespoke GMP manufacturing facility, and secured $65 M in funding while growing operations to 90+ employees across multiple sites. Currently, I’m driving innovation in the drug-development CRO market by deploying automated, tech-driven platforms in GLP environments to accelerate clinical timelines and upend the legacy CRO market. I’m passionate about delivering technology-first solutions to accelerate the drug lifecycle that actually make a meaningful impact on patient outcomes.
Disclosure information not submitted.
Accelerating Clinical Bioanalysis: Transforming the Industry with Automation and AI
Wednesday, July 16, 2025
3:30 PM - 4:00 PM ET